Laure-Anne Teuwen, MD, PhD, debates the real-world advantages of subcutaneous pembrolizumab.
|Videos|April 5, 2011
Dr. Dreicer Talks About the State of the Healthcare System
Author(s)Robert Dreicer, MD
Advertisement
Robert Dreicer, MD from Taussig Cancer Institute Talks About the State of the Healthcare System
Advertisement
Related to this article
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
Alpha DaRT Plus Pembrolizumab Yields 100% ORR in Elderly Recurrent or Metastatic HNSCC
4
Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL
5